Cancer Research AACR Legacy  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 2238-2241, June 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stanberry, L. R.
Right arrow Articles by Beattie, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stanberry, L. R.
Right arrow Articles by Beattie, C. W.

Biological Behavior of MM1 Hamster Melanoma1

Lawrence R. Stanberry2, Tapas K. Das Gupta and Craig W. Beattie3

Department of Pharmacology [L. R. S., C. W. B.], Division of Surgical Oncology [T. K. D. G., C. W. B.] and Department of Surgery, University of Illinois at the Medical Center, Chicago, Illinois 60612

We have reported evidence recently for a high-affinity receptor for glucocorticoid Malignant Melanoma No. 1 hamster melanoma and suggested that tumor growth was facilitated by adrenal steroids. This report characterizes the behavior of Malignant Melanoma No. 1 following manipulation of the pituitary-adrenal axis in vivo. Bilateral adrenalectomy significantly retarded tumor growth. Hypophysectomy also significantly reduced tumor growth. Silastic implants of hydrocortisone in intact hamsters produced a dose (7 to 28 µg/day)-related increase in tumor growth. Implants releasing a low dose (3 µg/day) of dexamethasone also increased tumor growth. Chronic exposure of adrenalectomized and intact hamsters to a high dose (125 µg/day) of desoxycorticosterone acetate also produced a significant increase over adrenalectomized and shamadrenalectomized controls. In contrast, chronic administration of adrenocorticotropic hormone and {alpha}-melanocyte-stimulating hormone to intact hamsters did not significantly alter melanoma growth. These observations support the suggestion that adrenocorticosteroids influence the growth of Malignant Melanoma No. 1 hamster melanoma and provide a model for studying the regulation of growth of a glucocorticoid-positive neoplasm originating outside the reticuloendothelial system.

1 This study was supported by the Cancer Research Fund, Carol Thomas Brigham Fund, and NIH Grant BRSG 7870. This is Paper 1, Effect of Adrenal Manipulation of Tumor Growth, of a series.

2 Submitted as partial fulfillment of requirements for Doctor of Philosophy, Department of Pharmacology, University of Illinois Medical Center, Chicago, Ill. Present address: Department of Pediatrics, University of Utah Medical Center, Salt Lake City, Utah 84132.

3 To whom requests for reprints should be addressed, at Division of Surgical Oncology, Department of Surgery, University of Illinois Medical Center, P. O. Box 6998, Chicago, Ill. 60680.

Received 4/23/81. Accepted 1/ 5/82.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.